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respiratory muscle activity and patient–ventilator 
asynchrony during different settings of noninvasive 
ventilation in stable hypercapnic COPD: does high 
inspiratory pressure lead to respiratory muscle 
unloading?
Marieke l Duiverman1
anouk s huberts2
leo a van eykern3
gerrie Bladder1
Peter J Wijkstra1
1Department of Pulmonary Diseases 
and home Mechanical Ventilation, 
University Medical Centre groningen, 
2Faculty of Medical sciences, 
University of groningen, 3Inbiolab 
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Introduction: High-intensity noninvasive ventilation (NIV) has been shown to improve out-
comes in stable chronic obstructive pulmonary disease patients. However, there is insufficient 
knowledge about whether with this more controlled ventilatory mode optimal respiratory muscle 
unloading is provided without an increase in patient–ventilator asynchrony (PVA). 
Patients and methods: Ten chronic obstructive pulmonary disease patients on home 
mechanical ventilation were included. Four different ventilatory settings were investigated in 
each patient in random order, each for 15 min, varying the inspiratory positive airway pres-
sure and backup breathing frequency. With surface electromyography (EMG), activities of the 
intercostal muscles, diaphragm, and scalene muscles were determined. Furthermore, pressure 
tracings were derived simultaneously in order to assess PVA. 
Results: Compared to spontaneous breathing, the most pronounced decrease in EMG activity 
was achieved with the high-pressure settings. Adding a high breathing frequency did reduce 
EMG activity per breath, while the decrease in EMG activity over 1 min was comparable with 
the high-pressure, low-frequency setting. With high backup breathing frequencies less breaths 
were pressure supported (25% vs 97%). PVAs occurred more frequently with the low-frequency 
settings (P=0.017). 
Conclusion: High-intensity NIV might provide optimal unloading of respiratory muscles, 
without undue increases in PVA. 
Keywords: electromyography, high-intensity NIV, chronic obstructive pulmonary disease, 
ineffective efforts
Introduction
Chronic obstructive pulmonary disease (COPD) is a chronic disease with a high 
mortality and morbidity worldwide.1 Patients with end-stage COPD frequently develop 
chronic hypercapnic respiratory failure (CHRF), which is associated with end of life. 
In that stage of disease, treatment options are limited.
Long-term application of intermittent noninvasive ventilation (NIV) in stable hyper-
capnic COPD patients has long been controversial.2–8 However, with the introduction 
of high-intensity NIV, ie, the use of higher inspiratory positive airway pressure (IPAP) 
levels in combination with a higher backup breathing frequency (BF), clear benefits 
of long-term NIV have been shown in stable COPD patients with CHRF.9–17 
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However, several issues with regard to high-intensity 
NIV remain unknown. For example, it is unknown what the 
contribution of the high IPAP levels and high backup BF is 
to not only the positive effects (respiratory muscle unload-
ing, improvement in gas exchange) but also the theoretical 
disadvantages (such as increased hyperinflation, increased 
patient–ventilator asynchrony [PVA]). A small crossover trial 
showed that high-pressure NIV compared with high-intensity 
NIV did not result in less improvement in gas exchange, nor 
were there any differences in patient compliance.18 However, 
respiratory muscle unloading and PVA were not assessed, 
patient numbers were small and drop-out substantially.
Surface respiratory electromyography (EMG) has been 
used by our group extensively.19,20 Recently it was shown 
that parasternal EMG can be used to assess PVA in patients 
initiated with home NIV.21 Its noninvasive character makes 
the method extremely useful during NIV, also for repeated 
measurements. 
Therefore, this study aimed to assess the degree of 
respiratory muscle unloading and PVA by means of surface 
EMG during different settings of NIV in stable hypercapnic 
COPD patients.
Methods
subjects
Ten randomly selected COPD patients already instituted on 
home mechanical ventilation (HMV) were included. At the 
time of the study, 65 COPD patients with CHRF were ven-
tilated noninvasively by our HMV center of the University 
Medical Center Groningen, with COPD being a minority 
of the HMV patients in the Netherlands. Characteristics of 
the included patients were similar compared to the other 
COPD patients on NIV in our center. Every 3–6 months, 
all patients on HMV visit our outpatient clinic for a regular 
control visit. During these control visits different ventilatory 
settings with varying pressures and breathing frequencies 
are regularly checked, as was done in the included patients. 
Because this titration is part of regular control visits, and 
the measurements performed are noninvasive and without 
any risk, ethical approval was deemed to be not necessary 
by the Medical Ethical Committee of the University Medi-
cal Center Groningen. Patients were asked beforehand by 
telephone if they agreed that an EMG measurement would 
be added to the regular protocol and were informed about 
the purpose of this measurement. Completion of testing is 
deemed to be agreement of consent from all participants. 
Patients already instituted on NIV were chosen, so exces-
sive loading/asynchronies because of being not accustomed 
to the mask or machine were prevented. All patients were 
originally instituted on NIV because of stable COPD with 
CHRF (PaCO
2
 .6.0 kPa in stable condition, pH .7.35, no 
exacerbation in the previous month). 
experimental protocol and ventilatory 
settings
Four different settings were investigated in each patient, as 
we do in regular care. The only difference was that, for study 
purposes, these settings were investigated systematically and 
in random order. Settings were investigated for 15 min in 
random order, with 10 min spontaneous breathing in between 
the ventilation periods to return to baseline level.
Four different settings were investigated in each patient:
1) low-pressure, low-frequency NIV (LPLF: IPAP at least 
10 cm H
2
O lower compared to the high pressure, with a 
maximum of 20 cm H
2
O; BF 10 breaths/min)
2) high-pressure, low-frequency NIV (HPLF: IPAP .25 
and #34 cm H
2
O; BF 10 breaths/min)
3) low-pressure, high-frequency NIV (LPHF: IPAP at least 
10 cm H
2
O lower compared to the high pressure, with 
a maximum of 20 cm H
2
O; BF 2 breaths/min above the 
patients’ own spontaneous BF) 
4) high-pressure, high-frequency NIV (HPHF: IPAP high-
est tolerable level, ie, between 25 and 34 cm H
2
O; BF 
2 breaths/min above the patients’ own spontaneous BF).
Expiratory positive airway pressure (EPAP) is regularly 
titrated in our center in order to overcome upper airway 
obstructive events with a minimum EPAP of 4 cm H
2
O. 
Because this study did not have the aim to investigate dif-
ferent EPAP levels too, EPAP was left at the EPAP used by 
the patients at home.
All patients were tested with their own home ventilator 
(BiPAP Synchrony®, Respironics, Philips, the Netherlands, 
in 3 patients and BIPAP Trilogy®, Respironics Trilogy 202®, 
Philips, the Netherlands, in 7 patients), in the spontaneous 
timed mode. Inspiration time was set at the shortest time 
without loss of patient comfort as we routinely do (mean 
inspiration time: 0.93 s [range 0.8–1.0 s]). Rise time is 
regularly set at the shortest level as possible, and was left at 
the home setting during the different settings (median 1.0) 
(the quickest rise time possible at the ventilator used [range 
1.0–4.0]). Triggers were set at the Auto-Track algorithm of 
both ventilators, adjusting to changing breathing patterns 
and dynamic leaks. All patients were ventilated with a full 
face mask. 
To test reproducibility of the measurement, all patients 
were investigated twice according to exactly the same 
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protocol, so that in total 4×10×2=80 periods (20 periods per 
setting) were investigated. 
Measurements
electromyography
Electrical activity of the scalene muscles (Sc), intercostal 
muscles (Int), and diaphragm (Dia) were derived from tran-
scutaneous electrodes (DEMCON - Macawi Respiratory 
Systems BV, Enschede, the Netherlands).19,20 
electrode placement
To obtain electrical activity of the Intercostal muscles, the 
electrodes were placed bilaterally in the second intercostal 
space, about 3 cm parasternal. Frontal Dia activity was 
obtained from one pair of electrodes placed bilaterally at the 
costal margin in the nipple line. Dorsal Dia activity was mea-
sured by a pair of electrodes placed bilaterally on the same 
height as the frontal electrodes, below the scapulae. Scalene 
activity was derived from bipolar electrode pairs placed on 
the neck on both sides. A common (ground) electrode was 
placed at the level of the sternum. 
Data acquisition and preprocessing
The electrodes were connected through low noise cables to 
the Dipha®-16 (DEMCON - Macawi Respiratory Systems 
BV, Enschede, the Netherlands), a battery-powered amplifier 
transmitting data to a transceiver USB dongle connected to 
a personal computer. 
Electrical heart activity, which interferes with Dia EMG 
signals, was removed according to the process described in 
Figure S1 of the Supplementary materials.
eMg processing
To determine the peak and bottom values of the respiratory 
EMG, the averaged EMG signals were resampled at 10 Hz 
in streaming amplitude histograms with a time window of 
30 s. Every 10 s the 5th and 95th percentiles were calculated 
serving as the bottom (5th) and peak (95th) values of the 
respiratory EMG during the previous 30 s. The differences 
between the peak and bottom values were reported as the 
mean peak-to-peak values.
All data recording, processing, analysis, and reporting were 
conducted by the Polybench data-acquisition and processing 
package (Applied Biosignals GMBH, Weener, Germany). 
gas exchange and patient comfort
Transcutaneous measurement of the PCO
2
 (PtCO2) and 
oxygen saturation was performed (TOSCA®; Linde Medical 
Sensors AG., Basel, Switzerland). The ear lobe senor was 
attached at least 10 min before the measurement session 
started and values as displayed during the last minute 
of each setting were used for analyses. Patient comfort 
was tested by asking the patients to rate the amount of 
comfort with the particular setting afterwards on a Visual 
Analogue Scale (VAS; 0: very uncomfortable; 10: very 
comfortable).
Data analysis 
For analysis of the EMG activity all measurements (20 in 
total) were analyzed together. 
eMg activity 
The mean EMG activity of 10 successive breaths (mean EMG 
activity per breath) and the sum of the EMG activity over 
1 min (EMG time product; sum activity per minute) were 
calculated from the last minute of EMG measurement periods 
(spontaneous breathing and during the different settings), 
excluding periods with movement artefacts. Frontal and 
dorsal Dia activities were summed. For comparisons between 
settings, the EMG Activity Ratio (EMGAR) was used, which 
is the ratio of peak inspiratory muscle activity during NIV and 
peak activity detected during spontaneous breathing (both per 
breath as per minute). This EMGAR was used to correct for 
differences in amplitude of the EMG signal between patients 
(eg, by different electrode to muscle distance because of a 
different amount of subcutaneous fat).
Control of breathing and PVa 
To assess control of breathing and PVA, simultaneous EMG 
recordings were compared with pressure recordings. The 
pressure waves provided by the ventilator were measured 
with a pressure transducer placed between the mask and 
the tubes. 
Breaths were counted for the full periods of the particular 
setting (5–12 min, with the exception of the first minute of 
each interval) and numbers were calculated as percentage 
of the total number of breaths delivered by the ventilator 
that were counted. Periods of coughing, talking, moving, 
and so on were registered and during these periods breaths 
were not counted to prevent false judgment of artefacts as 
respiratory activity.
The number of pressure-supported (Figure S2) and 
pressure-controlled (Figure S3) breaths were counted, includ-
ing the following PVAs: ineffective efforts (Figure S4); 
autotriggering (Figure S5); double or multiple triggering 
(Figure S6); and cycling asynchronies (premature [Figure S7] 
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and delayed cycling [Figure S8]). For detailed descriptions and 
examples see the Supplementary materials (Figures S2–S8). 
statistics
According to the distribution of the data, mean and standard 
deviation (SD) or median and ranges are presented. Differ-
ences between settings were assessed with a Friedman test 
for multiple related samples, with pairwise comparisons with 
a Wilcoxon signed rank test. Reproducibility was tested with 
the use of Bland and Altman plots.22 Statistical analysis 
were conducted using SPSS (22.0) and Graphpad (Prism 6; 
Graphpad software, La Jolla, CA, USA). 
Results
Characteristics of the 10 included patients are summarized 
in Table 1. The ventilatory settings investigated are sum-
marized in Table 2. 
eMg results
Compared to spontaneous breathing, the median EMG activ-
ity of the Int and Dia per breath was decreased during all four 
NIV settings. However, sum EMG activity over 1 min was 
only reduced with the high-pressure settings and the LPLF 
setting and not with the LPHF setting (Table 3). 
Comparing the different settings, the decrease in respira-
tory muscle activity per breath was most pronounced when a 
high inspiratory pressure was combined with a high backup 
BF (Figure 1A).
Similar trends were true for the total EMG activity calcu-
lated over 1 min. However, although the number of breaths 
was significantly higher with the HF settings, the total activity 
per minute was decreased to a similar amount with the HPHF 
setting compared to the HPLF setting (Figure 1B). 
Individual eMg data
In 16 measurements, the HPHF setting was the setting with the 
most pronounced decrease in Dia muscle activity per breath 
compared to spontaneous breathing. In two measurements 
(of different patients), the HPLF setting was clearly more 
effective in reducing respiratory muscle load. Of interest, in 
8 of the 16 measurements where the HPHF setting was the 
most effective setting in reducing respiratory muscle load per 
breath, the reduction in sum activty per minute was most pro-
nounced with the HPLF setting. Also with the low frequency 
setting, these patients adapted to an equal pattern of control 
of ventilation, as the number of pressure controlled breaths 
was similar compared to the number of controlled breaths in 
the patients who had the most net effective unloading with 
the high frequency setting. Only 2 patients had totally or suf-
ficiently abolished EMG activity during the HPHF setting.
Control of breaths and PVa
With low backup BF, almost all breaths were pressure sup-
ported, whereas with high-frequency settings most breaths 
were pressure-controlled (Table 4). There was a weak but 
significant correlation between the percentage of pressure-
supported breaths and the Dia EMGAR per breath, indicating 
that in measurements with more pressure-supported breaths 
the decrease in EMG activity per breath with NIV compared 
to spontaneous breathing was less (less negative EMGAR) 
(r=0.34, P=0.002). 
A total of 19,094 breaths were analyzed for assynchrony. 
Triggering assynchronies were, in general, infrequent. 
However, triggering assynchronies occurred more in the 
HPLF setting compared to the other settings (Table 4). In 3 
HPLF measurements, IEs occurred very frequently (in 32%, 
34%, and 35% of the counted breaths). However, no differ-
ence was found in NIV efficiency (decrease in transcutaneous 
CO
2
 with this setting), decrease in EMG activity or comfort 
scores between these patients and the other patients. Cycling 
problems occurred very infrequently. 
There was no relationship between the percentage of 
PVAs and the decrease in PtCO
2
, VAS scores, or decrease 
in respiratory muscle activity with NIV. 
gas exchange and comfort
PtCO
2
 was only significantly decreased with HPLF ventilation 
compared to spontaneous breathing (Figure 2). Participants 
judged the LPLF (median VAS score 8.2 [IQR 5.1–9.3]) and 
the HPHF setting (median VAS score 6.1 [IQR 4.3–8.0]) as 
the most comfortable, significantly more comfortable com-
pared to the LPHF (median VAS score 4.7 [IQR 3.0–7.4]) and 
HPLF (median VAS score 5.3 [IQR 1.3–9.2]) setting. 
Table 1 Patient characteristics
Characteristics
age, year, mean ± sD 66±8
Years on home nIV, median (range) 5 (1.3–9.2)
lTOT, % of patients 50
FeV1, l, mean ± sD 0.85±0.31
FVC, l, mean ± sD 2.65±0.79
FeV1/FVC, % 30±7
PaCO2 before nIV, kPa, mean ± sD 7.9±1.3
PaO2 before nIV, kPa, mean ± sD 8.3±1.7
PaCO2 at last control visit, kPa, mean ± sD 6.9±1.3
PaO2 at last control visit, kPa, mean ± sD 9.5±2.1
Abbreviations: sD, standard deviation; nIV, noninvasive ventilation; lTOT, long-
term oxygen therapy; FeV1, postbronchodilator forced expiratory volume in 1 s in 
liters (l); FVC, forced vital capacity in liters (l); PaO2, arterial oxygen pressure at 
daytime without ventilation; PaCO2, arterial carbon dioxide pressure at daytime 
without ventilation; kPa, kilopascal.
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Table 2 The different ventilatory settings investigated and the breathing frequency adopted by the patients
Ventilatory 
setting
IPAP, cm H2O, 
median (range)
EPAP, cm H2O, 
median (range)
Ventilator BF, breaths/
min median (range)
Patient BF, breaths/
min median (range)
Own home settings 28 (25–30) 6 (4–9) 18 (13–22)
lPlF 18 (18–20) 6 (4–9) 10 20 (12–25)
hPlF 30 (28–34) 6 (4–9) 10 16 (10–26)
lPhF 18 (18–20) 6 (4–9) 22.5 (16–25) 25 (16–27)
hPhF 30 (28–34) 6 (4–9) 22.5 (16–25) 23 (15–27)
Abbreviations: lPlF, low-pressure/low-frequency setting; hPlF, high-pressure/low-frequency setting; lPhF, low-pressure/high-frequency setting; hPhF, high-pressure/
high-frequency setting; IPaP, inspiratory positive airway pressure; ePaP, expiratory airway pressure; ventilator BF, breathing frequency set by the ventilator; patient BF, 
breathing frequency adopted by the patient, calculated as the number of patient efforts per minute on the eMg tracings.
Table 3 eMg activity per breath (average over 10 breaths) and total eMg activity in 1 min during the spontaneous breathing period 
before the nIV setting and during the selected nIV settings
EMG activity 
(microvolts)
SB LPLF SB HPLF SB LPHF SB HPHF
Int – per breath 1.98 
(1.3–4.1)
1.22 
(0.6–2.1)*
2.19 
(1.4–3.5)
1.18 
(0.3–2.5)**
1.80 
(1.4–2.7)
1.38 
(0.5–2.8)**
2.36 
(1.4–3.4)
0.64 
(0.10–1.9)**
Int – total 1 min 43.7 
(34–59)
24.1 
(15–31)**
42.4 
(30–48)
17.7 
(4–41)**
42.4 
(34–49)
31.5 
(11–65)
40.7 
(33–57)
13.6 
(6–35)**
Dia – per breath 9.86 
(5.9–14.1)
6.52 
(2.9–7.9)**
8.67 
(5.9–13.7)
4.07 
(2.4–6.7)*
8.17 
(6.2–12.1)
7.57 
(3.6–11.5)**
9.51 
(5.9–12.6)
2.94 
(1.0–4.9)**
Dia – total 1 min 180.8 
(134–210)
103.8 
(67–144)**
186.7 
(153–215)
69.5 
(38–125)*
169.5 
(129–216)
150.9 
(100–261)
178.0 
(117–205)
75.3 
(36–129)**
sc – per breath 2.07 
(0.9–3.6)
1.38 
(0.6–2.8)
2.52 
(1.1–3.9)
1.27 
(0.5–2.0)
2.19 
(0.7–3.8)
1.84 
(0.7–3.9)
3.01 
(1.4–3.9)
1.31 
(0.4–2.4)**
sc – total 1 min 40.8 
(21–77)
21.8 
(15–52)
38.6 
(27–69)
16.9 
(11–62)
43.3 
(17–72)
37.6 
(17–85)
40.2 
(17–79)
27.5 
(11–46)
BF (breaths/min) 21.5 
(11–28)
19.8 
(12–25)
18.2 
(15–23)
15.8 
(12–21)
20.3 
(17–23)
24.6 
(22–26)**
17.8 
(15–21)
23.4 
(22–24)**
Notes: raw eMg data were not normally distributed, therefore median and interquartile ranges are shown. *P,0.001 and **P,0.05 compared with a Mann–Whitney 
U-test.
Abbreviations: eMg, electromyography; Int, intercotal eMg activity; Dia, diaphragm eMg activity; sc, scalene eMg activity; BF, breathing frequency; sB, spontaneous 
breathing; lPlF, low-pressure, low-frequency setting; hPlF, high-pressure, low-frequency setting; lPhF, low-pressure, high-frequency setting; hPhF, high-pressure, high-
frequency setting. 
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Figure 1 eMg activity ratios (eMgars) with the different settings are shown per breath (A) and per minute (B).
Notes: entries shown are medians and interquartile ranges. low-frequency settings are shown in black (: lPlF setting; : hPlF setting), high-frequency settings are 
shown in gray (: lPhF setting;  hPhF setting). eMgar is the ratio between the eMg activity during nIV divided by the resting breathing eMg activity. For example, 
an eMgar of 0.29 for the diaphragm during the hPhF setting means a decrease in eMg activity with a factor 1/0.29=3.4 with this setting compared to resting breathing. 
*P,0.05, **P,0.01, and ***P,0.001.
Abbreviations: eMg, electromyography; lPlF, low-pressure, low-frequency setting; hPlF, high-pressure, low-frequency setting; lPhF, low-pressure, high-frequency 
setting; hPhF, high-pressure, high-frequency setting; nIV, noninvasive ventilation.
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reproducibility
Reproducibility was moderate to good for the intercostal 
muscles and for the Dia, while for the Sc reproducibility 
was low (Figure 3A–C).
Discussion
This study shows that in patients with stable COPD and 
CHRF, NIV decreases respiratory EMG activity, with a 
clearly more pronounced reduction in activity with the use 
of higher inspiratory pressures. Adding a high backup BF 
aimed at a total control of ventilation did lead to a further 
decrease in EMG activity per breath. However, total activ-
ity per minute was equally decreased compared to the 
low-frequency setting; as in the majority of patients EMG 
activity was not totally abolished to trigger and to cycle 
breaths, also not during the HPHF setting. However, PVAs 
Table 4 Patient-ventilator asynchrony during different settings
Control of breath and  
asynchrony event
LPLF HPLF LPHF HPHF
Breaths counted per measurement  
(requested and delivered) mean (range)
218 (110–325) 184 (73–325) 277 (137–284) 275 (160–361)
Pressure-supported, % of breaths* (range) 97 (83–100) 88 (39–100) 39* (2–99) 25 (0–100)
Pressure-controlled, % of breaths* (range) 2 (0–13) 10 (0–56)** 61 (1–98)* 74 (0–99)
Ineffective breaths
% of patients with at least 1 event 75 75 65 55
% of counted breaths, mean (range) 1.5 (0–9) 5.3 (0–26) 0.9 (0–3) 0.9 (0–9)
Patients with .10% of the asynchrony event, n 0 3# 0 0
autotriggering
% of patients with at least 1 event 70 65 40 45
% of counted breaths, mean (range) 1.9 (0–8)## 1.8 (0–9)### 0.4 (0–3) 0.9 (0–9)
Patients with .10% of the asynchrony event, n 0 0 0 0
Double or multiple triggering
% of patients with at least 1 event 20 60 30 25
% of counted breaths, mean (range) 0.3 (0–4)## 0.9 (0–5) 0.6 (0–6) 0.4 (0–4)
Patients with .10% of the asynchrony event, n 0 0 0 0
Total triggering asynchrony
% of patients with at least 1 event 95 90 70 55
% of counted breaths, mean (range) 3.7 (0–14) 8.0 (0–29) 1.8 (0–9) 2.2 (0–10)
Patients with .10% of the asynchrony event, n 2 6 0 0
Premature cycling
% of patients with at least 1 event 2 5 6 3
% of counted breaths, mean (range) 0.1 (0–1) 0.3 (0–3) 0.8 (0–6) 0.1 (0–1)
Patients with .10% of the asynchrony event, n 0 0
Delayed cycling
% of patients with at least 1 event 2 6 0 5
% of counted breaths, mean (range) 0.2 (0–2) 1.7 (0–16) 0 (0–0) 0.2 (0–3)
Patients with .10% of the asynchrony event, n 0 1 0 0
Total cycling asynchrony
% of patients with at least 1 event 4 10 7 7
% of counted breaths, mean (range) 0.3 (0–2) 2.0 (0–16) 0.7 (0–6) 0.5 (0–3)
Patients with .10% of the asynchrony event, n 0 2 0 0
Notes: Differences between the settings were tested with a Friedman test for multiple comparisons and pairwise comparisons with Mann–Whitney U-tests. *hF versus lF: 
P,0.001; **lPlF vs hPlF: P=0.001; #hPlF vs high-frequency settings: P=0.017; ##lPlF vs lPhF: P=0.001; and ###hPlF vs hPhF: P=0.036.
Abbreviations: lPlF, low-pressure/low-frequency setting; hPlF, high-pressure/low-frequency setting; lPhF, low-pressure/high-frequency setting; hPhF, high-pressure/
high-frequency setting.
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Figure 2 Transcutaneous carbon dioxide pressure (PtCO2) during spontaneous 
breathing and with the different settings.
Notes: shown are the PtCO2 values during the last minute of the prior spontaneous 
breathing period and during the last minute of the particular setting. *P,0.05.
Abbreviations: lPlF, low-pressure/low-frequency setting; hPlF, high-pressure/
low-frequency setting; lPhF, low-pressure/high-frequency setting; hPhF, high-
pressure/high-frequency setting.
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occurred more frequently with low-frequency settings, 
especially with the HPLF setting. The clinical relevance of 
the limited number of PVAs we found in our “experienced” 
NIV users can be questioned as the number of PVAs was 
low and not associated with increased respiratory muscle 
activity, reduced gas exchange, or discomfort experienced 
by the patients. 
Critique of the method used
Surface EMG of the respiratory muscles has recognized 
limitations, such as movement artefacts and potential cross-
talk from adjacent muscles. However, movement artefacts 
are easy to recognize, as all measurements were observed 
carefully by one of the investigators. Furthermore, in a 
resting condition, as was the case in this study, crosstalk 
by other chest wall muscles is believed to be minimal. Dif-
ference in electrode to muscle distance was corrected by 
using the EMG activity ratio, in which the EMG activity 
is expressed as a change in activity compared to resting 
breathing.19 
reproducibility
The three most important respiratory muscles – the Dia, 
the intercostal muscles, and the Sc – were included in all 
measurements as the different muscles can be recruited 
differently under different conditions.19,20 It should be 
noticed that Dia and intercostal signals were the most 
stable and reproducible signals, showing in most patients 
a consistent decrease with NIV. Agreement between the 
two days was found to be less in patients who were not 
used to these particular settings at home. In this respect, 
this study acknowledges that the short periods of measure-
ments (only 15 min) are a limitation and probably habitu-
ation might have played a role in some patients during the 
second measurement. 
The reproducibility of the scalene signals was low across 
all settings. Unfortunately, scalene signals were easily dis-
turbed, for example, by lifting the head or turning. Therefore, 
for future measurements this study recommends the use of 
intercostal and Dia signals only for measuring respiratory 
muscle activity during NIV. 
Patient–ventilator asynchrony
PVAs counting by comparing surface EMG signals with 
pressure signals has recently been shown to be a reliable 
method.21 This study primarily used the Dia signals, with an 
extra check by using the intercostal signals. This was done 
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Figure 3 reproducibility of the eMg of the intercostal muscles (A), diaphragm (B), and scalene muscles (C).
Notes: Bland & altman plots. shown are mean eMgar measurements 1 and 2 on the x-axis and the difference (Diff) between those eMgars on the y-axis. The mean 
difference is shown with a straight line, with 95% CI with dashed lines (: lPlF setting; : hPlF setting; : lPhF setting; : hPhF setting). 
Abbreviations: eMg, electromyography; eMgar, eMg activity ratio; lPlF, low-pressure/low-frequency setting; hPlF, high-pressure/low-frequency setting; lPhF, low-
pressure/high-frequency setting; hPhF, high-pressure/high-frequency setting.
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while observing the most stable, consistent signals in the 
Dia EMG. 
gas exchange monitoring
Transcutaneous monitoring was used to obtain an indication 
of the effectiveness of the settings on gas exchange. Although 
transcutaneous measurements have been shown to reliably 
reflect gas exchange at least in the chronic setting,23–26 it also 
has drawbacks: the monitor requires 10 min for equilibra-
tion, and may not reliably reflect arterial PaCO
2
 in some 
circumstances (eg, when arterialization of the ear lobe is 
limited). However, in this clinical practice protocol a practical 
and patient friendly approach was followed as is regularly 
done to titrate patients on NIV, with more and more use of 
noninvasive transcutaneous measurements. To allow equili-
bration, for analysis, the PtCO
2
 value was used during the 
last minute of each period. Importantly, the study accepted 
some drawbacks as PtCO
2
 was only a secondary outcome; the 
study did not primarily aim to investigate changes in PCO
2
 
with different settings. 
Physiological observations
respiratory muscle activity with nIV
For more than 10 years now, the concept of using higher 
inspiratory pressures has been shown to bring clear benefits 
in terms of improvement in gas exchange, exercise tolerance, 
lung function, and survival.9,11–13,16,17 In these studies, high 
pressures were combined with a high backup BF, as it was 
hypothesized that with a more controlled form of ventilation 
hypoventilation was counterbalanced most effectively and 
the patient was “rested” most.9,16 However, evidence for this 
high backup frequency per se is lacking, probably only a high 
inspiratory pressure will be sufficient to achieve benefits. 
Our study shows that high inspiratory pressures indeed 
decrease respiratory muscle activity substantially compared 
to resting breathing. The effects of the addition of a high 
backup BF, however, is more complex. A pattern of rapid 
shallow breathing has been regarded beneficial in severe 
COPD as muscle fatigue is hypothesized to be prevented 
in this way.27 Although the Dia of COPD patients is regarded 
to be adapted to chronic loading by a muscle fiber-type shift 
toward more oxidative type I, fatigue-resistant fibers,28 it is 
more susceptible to sacromeric injury induced by higher 
inspiratory loads.29 As so, the study hypothesized that a pat-
tern of breathing with less respiratory muscle activity per 
breath is preferable, despite the fact that total inspiratory 
load per minute was equally decreased with the HPHF setting 
compared to the HPLF setting. 
Our data also nicely show that inactivity-induced dia-
phragm atrophy, as has been shown to occur during controlled 
mechanical ventilation,30 should not be feared, even not with 
HPHF NIV, because EMG activity and patient-triggered 
breaths persisted even with the HPHF setting. Furthermore, 
patients on home NIV always have periods of spontaneous 
breathing in between. Of course, this study acknowledges that 
measurements were done at daytime. It would be interesting 
to compare the settings during a full night.
Of note, the backup BF level with which individual 
patients reached the most reduction in EMG activity was 
not uniformly the HPHF setting. Choosing a too high 
backup frequency can lead to a short expiratory time and 
thereby dynamic hyperinflation, thus increasing the work of 
breathing.31,32 Therefore, it would be interesting to use our 
EMG to titrate the optimum BF individually in order to 
optimize respiratory muscle rest. 
Patient–ventilator asynchrony
The prevalence of PVA in this study was moderate to low 
in comparison to other studies.21,33–37 Several reasons might 
explain these differences. 1) The method used to detect PVA 
differs between the studies. This study believes that respira-
tory EMG being a direct parameter of respiratory drive is 
preferable to represent patients’ wishes, instead of an indirect 
parameter such as respiratory movements by bodyplethys-
mography or flow measurements. Recently, reliable results 
have been shown with the use of parasternal (intercostal) 
EMG.21 2) The patients were long-term NIV users in stable 
condition, in whom PVAs were found to be considerably 
lower. 3) The measurements were performed at daytime, 
when patients were awake. In the study of Fanfulla et al no 
IEs were observed when patients were awake, whereas 4.7% 
IEs were observed while the patients were asleep.38 4) Venti-
latory settings influence the prevalence of PVA.33,37,39–41 
The occurrence of PVA is complex and affected by both 
patient-related factors, such as respiratory drive, respiratory 
muscle strength, increased inspiratory load due to augmented 
airway resistance, and ventilator-related factors, such as mask 
leaks and ventilatory settings.34 An important mechanism 
implicated in the genesis of PVA is dynamic hyperinflation. 
Dynamic hyperinflation might be a consequence of a too 
short expiratory time, which can be the case with high BF, 
or high IPAP, levels. Dynamic hyperinflation increases 
the work of breathing and might induce IEs, as inspiratory 
resistance has to be overcome before the patient can generate 
a negative inspiratory flow to trigger the ventilator. In this 
study, surprisingly, most triggering PVAs occurred during 
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the low-frequency settings. Furthermore, this increased 
number of PVAs during the LF settings was caused by only 
a small number of patients showing a relevant number of 
PVAs, indicating that careful individual attention should be 
paid to this issue. In one patient mask leaks occurred. Mask 
leaks may cause ineffective efforts and autotriggering as 
the ventilator is unable to detect the patient’s inspiratory 
effort,42 and delayed cycling, as the ventilator does not cycle 
to exhalation once the flow remains below a certain level.37 
However, it has also been shown that the home ventilators 
perform far better compared with nonhome ventilators in leak 
compensation.33 This may be one of the reasons why PVAs 
were so infrequent in our cohort of patients. 
In another patient, exceptionally high patient-driven BF 
might have resulted in dynamic hyperinflation, especially 
during the ST mode used in the study. In this mode the 
inspiratory time of patient-triggered breaths is not limited and 
expiratory time might become too short to exhale completely 
back from the high volume inflated with high inspiratory 
pressures used. Switching to a higher backup BF solved this 
problem, as most breaths became ventilator-triggered with a 
set (short) inspiratory time. Only one patient had a relevant 
incidence of double triggering (6%), with the HPLF setting. 
This might reflect a too high demand in comparison to the 
delivered minute volume, reflected by a high respiratory rate 
(spontaneous BF 25/min), which was, despite high pressures 
(IPAP 25 cm H
2
O), not completely met by the ventilator. 
This high demand was also confirmed by the fact that this 
was the only patient in whom EMG activity did not decrease 
during NIV. 
In summary, COPD patients on long-term NIV are able 
to adjust easily to several settings of NIV, resulting in 
infrequent PVAs. Importantly, this study found that a high 
backup BF does not promote the occurrence of PVAs nor 
does it decrease patient satisfaction with the setting. The 
clinical relevance of PVAs in stable COPD patients on NIV 
however is questionable, as they occur in very low frequen-
cies, and in this study, also in other studies, gas exchange, 
patient comfort, or overall respiratory drive was not affected. 
Therefore, there is no evidence that the occurrence of infre-
quent PVAs is a reason to change settings. In individual cases, 
however, it is worthy to examine PVA, as this might affect 
ventilatory efficiency. 
Conclusion
NIV with high inspiratory pressures might be required to 
provide optimal respiratory muscle rest and optimal improve-
ment in gas exchange in stable hypercapnic COPD patients. 
The effects of the addition of a high backup frequency on 
respiratory muscle unloading were individually different. 
On the one hand, adding a high backup might provide 
optimal muscle unloading, without completely controlling 
ventilation, and with little PVAs. On the other hand, a too 
high backup frequency might be disadvantageous, also with 
respect to respiratory muscle unloading. Further research, in 
a larger group of patients, is necessary to optimize the backup 
BF, as probably individual titration is necessary to choose 
its optimal setting.
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Supplementary materials
Methods
eMg data acquisition and preprocessing
Electrical heart activity, which interferes with diaphragm 
electromyography (EMG) signals, was removed according 
to the process described in Figure S1. 
Control of breathing and patient–ventilator 
asynchrony 
Control of the breaths and triggering 
Pressure-supported breath (Figure s2)
Pressure-supported (PS) breaths are breaths delivered by the 
ventilator following a trigger from the patient. By definition, 
a PS breath was counted once the diaphragm and/or intercostal 
EMG signal preceded the onset of the pressure wave. 
Pressure-controlled breath (Figure s3)
Pressure-controlled (PC) breaths are breaths delivered by the 
ventilator without a trigger from the patient. By definition, 
a PC breath was counted once the diaphragm and/or 
intercostal EMG signal followed the onset of the pressure 
wave or was totally abolished. 
Patient–ventilator asynchrony 
We counted the following patient–ventilator asynchrony 
(PVAs): ineffective efforts (Figure S4); autotriggering 
(Figure S5); double or multiple triggering (Figure S6); and 
cycling asynchronies (premature [Figure S7] and delayed 
cycling [Figure S8]). 
(0*G
456
(0*J
(0*D
%DQG
V
Figure S1 The Qrs removal process.
Notes: The averaged eMg (eMga) shows respiratory activity. as control the signal from the abdominal magnetometer band (Band) is shown. From the diaphragmatic 
eMg signal (eMgd), the Qrs complex was detected and stretched into a standard Qrs pulse with a duration of 100 ms (Qrs). During the Qrs pulse a cut was made in 
the slightly delayed (40 ms) EMG signal to completely filter out the QRS complex (EMGg). Next, the gated EMG was rectified and averaged with a moving time window of 
200 ms. Finally, the missing signal in the gate was filled with the running average resulting in a fairly good interpolation during the gate and an almost QRS-free averaged EMG 
signal (eMga).
Abbreviation: eMg, electromyography.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
9.
12
5.
16
6.
19
0 
on
 2
0-
Ju
n-
20
17
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2017:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
254
Duiverman et al
V

±

±

±

±




,QWUDZ
)'LDUDZ
''LDUDZ
3DZ
,QWHUF
)'LD
''LD
±
±
 
Figure S2 a pressure-supported (Ps) breath.
Notes: shown are (from top to bottom) the raw intercostal signal (Int raw), the raw frontal diaphragm signal (F Dia raw), the raw dorsal diaphragm signal (D Dia raw), the 
pressure wave (Paw), the average intercostal signal (Interc), the average frontal diaphragm (F Dia) signal, and the average dorsal diaphragm signal (D Dia). Two Ps breaths 
are shown, as electromyography activity (the dotted red line) precedes the pressure wave (the straight blue line). a low backup frequency of 10 breaths/min was set on the 
ventilator, therefore a 2.6 s time in-between the breaths confirms that breaths were PS and not pressure-controlled (PC).
Abbreviation: eMg, electromyography.
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Figure S3 a pressure-controlled (PC) breath.
Notes: shown are (from top to bottom) the raw intercostal signal (Int raw), the raw frontal diaphragm signal (F Dia raw), the raw dorsal diaphragm signal (D Dia raw), the 
pressure wave (Paw), the average intercostal signal (Interc), the average frontal diaphragm (F Dia) signal, and the average dorsal diaphragm signal (D Dia). Two PC breaths 
are shown, electromyography activity (the dotted red line) appears but after the pressure wave (the straight blue line) started. This is a tracing during a high-pressure, 
high-frequency setting, with a backup frequency of 22 breaths/min, so that an in-between breath time of 2.7 s means that the ventilator delivers a breath at the moment it is 
supposed to do according to the set-up backup frequency. Of note, electromyography activity was much lower with this setting.
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Figure S4 an ineffective effort.
Notes: shown are (from top to bottom) the raw intercostal signal (Int raw), the raw frontal diaphragm signal (F Dia raw), the raw dorsal diaphragm signal (D Dia raw), the 
pressure wave (Paw), the average intercostal signal (Interc), the average frontal diaphragm (F Dia) signal, and the average dorsal diaphragm signal (D Dia). an electromyography 
signal (dotted red line) was not followed by a breath delivered by the ventilator (straight arrow blue line).
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Figure S5 autotriggering.
Notes: shown are (from top to bottom) the raw intercostal signal (Int raw), the raw frontal diaphragm signal (F Dia raw), the raw dorsal diaphragm signal (D Dia raw), the 
pressure wave (Paw), the average intercostal signal (Interc), the average frontal diaphragm (F Dia) signal, and the average dorsal diaphragm signal (D Dia). During this low-
frequency setting (backup frequency 10 breaths/min), the two breaths denoted by arrows come too soon to be PC. As it is not preceded by EMG activity, these are defined 
as inappropriate autotriggered breaths (straight blue lines).
Abbreviations: eMg, electromyography; PC, pressure-controlled.
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Figure S6 Double triggering. 
Notes: shown are (from top to bottom) the raw intercostal signal (Int raw), the raw frontal diaphragm signal (F Dia raw), the raw dorsal diaphragm signal (D Dia raw), 
the pressure wave (Paw), the average intercostal signal (Interc), the average frontal diaphragm (F Dia) signal, and the average dorsal diaphragm signal (D Dia). a single 
electromyography wave (dotted red line) is followed by two ventilator delivered breaths (nr.1 and nr.2 straight blue lines). 
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Figure S7 Premature cycling. 
Notes: shown are (from top to bottom) the raw intercostal signal (Int raw), the raw frontal diaphragm signal (F Dia raw), the raw dorsal diaphragm signal (D Dia raw), the 
pressure wave (Paw), the average intercostal signal (Interc), the average frontal diaphragm (F Dia) signal, and the average dorsal diaphragm signal (D Dia). electromyography 
activity (the maximum of the electromyography is depicted by the red dotted line) continues, while the pressure returns to baseline again (the end of the inspiratory pressure 
delivering is depicted by the blue dotted line). 
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Figure S8 Delayed cycling.
Notes: shown are (from top to bottom) the raw intercostal signal (Int raw), the raw frontal diaphragm signal (F Dia raw), the raw dorsal diaphragm signal (D Dia raw), the 
pressure wave (Paw), the average intercostal signal (Interc), the average frontal diaphragm (F Dia) signal, and the average dorsal diaphragm signal (D Dia). The electromyography 
activity has already ceased (end of the electromyography activity depicted by the red dotted line), while the pressure wave continues, (end of the breaths depicted by the 
straight blue line). 
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